Skip to main content

The figures include expenditure relating to dispensing by GP practices. They do not include the costs of drugs dispensed by high street pharmacies.

View previous publications.

Summary of reported investment from 2016 to 2021

Table 2a: Summary of reported investment from 2016 to 2021
     £ thousands
 2016/20172017/20182018/20192019/20202020/2021
Global sum/MPIG262,886274,362295,599300,022308,864
Quality42,338           42,334  42,33750,224 47,631
      
Direct enhanced services (GMS)21,44124,75632,30031,30530,126
National enhanced services (GMS) 7,8789,5495,2886,7323,333
Local enhanced services13,45214,39913,26514,83623,069
Total enhanced services42,771            48,704 50,853  52,874 56,528
      
Premises48,31740,77742,384 42,44042,218
PCO administered funds15,76818,54820,11223,33626,578
Out of hours (incl. OOH Development Fund35,59236,14037,53738,70540,323
IT (including centrally funded IM and T)13,54813,90016,89914,98714,000
Total other payments113,225109,365116,932119,468123,119
Subtotal461,220474,765505,721522,588536,142
      

Country specific investment

     
National primary care fund: direct practice payments 5,4345,7965,1554,858
National primary care fund: Investment on behalf of GP practices 14,26620,68522,01422,412
Total country specific investment 19,70026,48127,16927,270
      
Total net of dispensing461,220494,465532,202549,757563,412
      
Cost of dispensing fees (including DSQS) (1)12,288                      11,89412,78512,02414,289
Total investment excluding reimbursement of drugs (2)473,508506,359544,987561,781577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts)37,76737,50038,30740,19639,461
Total spend (3)511,275543,859583,294601,977617,162

In 2020/21 there was an increase in the total investment in GP practices of £15.1 million compared to the published 2019/20 figures. 

  1. For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.       
  2. Total investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.    
  3. For 2017 to 18 and 2018 to 19 includes costs for one APMS contract. 

Note:

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.   
  • National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Reported investment in general practice 2020 to 2021

 
Table 2b: Reported Investment in general practice 2020 to 2021
 £ thousands
 Outturn
Global sum304,906
MPIG correction factor3,958
Total global sum and MPIG308,864
  
Quality aspiration payments9,927
Quality achievement payments5,164
Quality assurance improvement framework (QAIF)23,828
QAIF (In hours Access)8,712
Total quality 47,631
  
Direct enhanced services30,126
National enhanced services3,333
Local enhanced services23,069
Total enhanced services56,528
  
Premises42,218
PCO administered funds26,578
Out of hours40,323
IM and T14,000
Total other payments123,119
Subtotal536,142

Country specific investment

 
National primary care fund: direct practice payments4,858
National primary care fund: Investment on behalf of GP practices22,412
Total country specific investment27,270
  
Total net of dispensing563,412
  
Dispensary Services Quality Scheme (DSQS)493
Cost of dispensing fees (including DSQS) (1)13,796
Total of all dispensing fees14,289
  
Total investment excluding reimbursement of drugs (2)577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts)39,461
Total spend617,162
  1. For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.   
  2. Total Investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.   

Note: 

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.    
  • National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Supplementary information 2020 to 2021

Table 2c: Supplementary information 2020 to 2021
 £ thousands
 Outturn

Direct enhanced services

 
Asylum seekers and refugees2
Care of diabetes1,045 
Care homes3,561 
Childhood vaccination and immunisation scheme6,044
Extended opening times694
Homeless56
Influenza and pneumococcal immunisations scheme11,249
Learning disabilities294
Mental health58
Minor surgery fees2,348
Services for violent patients168 
Oral anticoagulation with Warfarin4,586
Gender identity21
Total direct enhanced services30,126

PCO administered funds

 
Seniority5,502
Doctors retainer scheme payments421
Locum allowances consisting of: 
a) Adoptive, paternity and maternity2,804
b) Sickness1,557
c) Suspended doctors326
d) Other locum payments52

Appraiser costs

 
Recruitment and retention (incl. golden hello)23
Primary care development scheme1,784
Partnership premium4,303
Designated area allowance 
Initial practice allowance 
Assistant's allowance 
Associate allowance 
Supply of syringes and needles 
Pneumococcal (campaign and catch up)
 
 
Other 9,806
Total PCO administered funds26,578

Other payments 

 
GP support costs451
Managed practice costs - managed practices8,546
Managed practice costs - managing practices 
Primary care initiatives 
GP practice training67

Translation service costs 

 
Other approved PCO administered costs 742
Total other payments9,806

Note:

  • Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.